Unlike Rottapharm, which announced yesterday morning the withdrawal of the IPO for the listing on Piazza Affari, "Sisal confirms that, despite the adverse conditions of the stock markets, the offer is still in progress". The company announced this in a statement yesterday.
Sisal does not imitate Rottpharm: IPO continues despite the difficult moment of the markets
The company "confirms that, despite the adverse conditions of the stock markets, the offer is still in progress".